|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1400 I STREET, NW, #1200 |
Address2 |
|
City | WASHINGTON |
State | DC |
Zip Code | 20005 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 27401-12
|
||||||||
|
6. House ID# 336830000
|
TYPE OF REPORT | 8. Year | 2017 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Matthew L. Myers |
Date | 7/18/2017 4:33:08 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOB
16. Specific lobbying issues
Legislation
H.R. 564 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2017 (Lobbying activities related to opposing exemption of cigars from FDA oversight)
S. 294 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2017 (Lobbying activities related to opposing exemption of cigars from FDA oversight)
H.R. 1136 FDA Deeming Authority Clarification Act of 2017 (Lobbying activities related to opposing bill to change the grandfather date for newly deemed products)
Senate Tobacco to 21 Act (Lobbying activities related to prohibiting the sale or distribution of tobacco products to individuals under the age of 21)
House Tobacco to 21 Act (Lobbying activities related to prohibiting the sale or distribution of tobacco products to individuals under the age of 21)
Senate Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017 (Lobbying activities related to FY 2017 appropriations for the Food and Drug Administration and protecting FDAs authority to oversee all tobacco products)
Senate FY2018 Appropriations for the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies (Lobbying activities related to FY 2018 appropriations for the Food and Drug Administration and protecting FDAs authority to oversee all tobacco products)
House Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017 (Lobbying activities related to FY 2017 appropriations for the Food and Drug Administration and protecting FDAs authority to oversee all tobacco products)
House FY2018 Appropriations for the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies (Lobbying activities related to FY 2018 appropriations for the Food and Drug Administration and protecting FDAs authority to oversee all tobacco products)
Senate Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017 (Lobbying activities related to FY 2017 appropriations for the Centers for Disease Control and Prevention)
Senate FY2018 Appropriations for the Departments of Labor, Health and Human Services, and Education, and Related Agencies (Lobbying activities related to FY 2018 appropriations for the Centers for Disease Control and Prevention)
House Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017 (Lobbying activities related to FY 2017 appropriations for the Centers for Disease Control and Prevention)
House FY2018 Appropriations for the Departments of Labor, Health and Human Services, and Education, and Related Agencies (Lobbying activities related to FY 2018 appropriations for the Centers for Disease Control and Prevention)
S. Con. Res. 3 - FY 17 Budget Resolution
H.R. 1628 American Health Care Act of 2017 (provisions related to coverage for tobacco cessation and Prevention Fund)
Senate health care reform bill (provisions related to coverage for tobacco cessation and Prevention Fund)
H.R. 1662 A bill to prohibit smoking in any facility of the Veterans Health Administration
H.R. 2194 Cigarette Smoking Reduction and Electronic Vapor Alternatives Act of 2017
Smuggled Tobacco Prevention Act (not yet introduced)
H.R. 244 the Consolidated Appropriations Act (lobbying related to FDA authority to regulate tobacco products and CDC tobacco prevention funding)
S. 951 the Regulatory Accountability Act
Issues
Nomination of Scott Gottlieb to be FDA Commissioner
Prevention and Public Health Fund (Lobbying activities related to preserving the Fund)
Tobacco cessation coverage in Medicaid
Tobaccos role in health disparities
ACA Coverage of tobacco cessation services in private insurance
FDA regulation of tobacco products
Implementation of FDAs Deeming Rule
Nomination of Noel Francisco for Solicitor General
United States Trade Representative efforts to renegotiate NAFTA
CDC tobacco control efforts
Smoke free Housing and Urban Development rule
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), U.S. Trade Representative (USTR)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Anne J. |
Ford |
|
|
|
Brian J. |
Hickey |
|
|
|
Luke C. |
George |
|
|
|
William P. |
Lee |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address: http://www.tobaccofreeaction.org/
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
Tobacco Free Kids Action Fund |
|
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |